Angelines Cruz

ORCID: 0000-0003-1382-4546
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Forensic Toxicology and Drug Analysis
  • Prenatal Substance Exposure Effects
  • Cannabis and Cannabinoid Research
  • Analytical Chemistry and Chromatography
  • Analytical Methods in Pharmaceuticals
  • Pesticide Residue Analysis and Safety
  • Heme Oxygenase-1 and Carbon Monoxide
  • Alcohol Consumption and Health Effects
  • Psychedelics and Drug Studies
  • Neurotransmitter Receptor Influence on Behavior
  • Poisoning and overdose treatments
  • Analytical chemistry methods development
  • Neuroscience of respiration and sleep
  • Metabolomics and Mass Spectrometry Studies
  • Substance Abuse Treatment and Outcomes
  • Smoking Behavior and Cessation
  • Opioid Use Disorder Treatment
  • Paraquat toxicity studies and treatments
  • Treatment of Major Depression
  • Advanced Chemical Sensor Technologies
  • Drug-Induced Adverse Reactions
  • Neonatal Health and Biochemistry
  • Antibiotics Pharmacokinetics and Efficacy
  • Forensic Anthropology and Bioarchaeology Studies
  • Methemoglobinemia and Tumor Lysis Syndrome

Universidade de Santiago de Compostela
2014-2024

University of Coimbra
2010

San Antonio College
2010

Universidad Colegio Mayor de Cundinamarca
2001

Amphetamine‐type‐stimulants (ATS) are the second most commonly used group of illicit drugs worldwide. However, in last few years, new psychoactive substances (NPS) with stimulant effects have appeared on illegal market, which not detected traditional analytical methods. A liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method for determination hair classic ATS (amphetamine, methamphetamine, 3,4‐methylenedioxymethamphetamine and 3,4‐methylenedioxyamphetamine), synthetic cathinones...

10.1002/dta.1948 article EN Drug Testing and Analysis 2016-02-24

Drug exposure during pregnancy constitutes a major legal issue and public health concern. metabolite determination in biological matrices from mother newborn is an objective indication of prenatal drug exposure. However, limited data are available regarding the interpretation these analytical results terms window detection degree We collected paired maternal hair, meconium, placenta, umbilical cord 727 mother-newborn dyads. analyzed specimens by liquid chromatography-tandem mass spectrometry...

10.1002/dta.2087 article EN Drug Testing and Analysis 2016-09-05

Drug of abuse consumption throughout pregnancy is a serious public health problem and an important economic cost to the system. The aim this work was compare maternal interview hair analysis determine drug study relations among interview, results, neonatal outcomes.Two hundred nine mothers agreed participate. After delivery, they were interviewed sample collected. Hair samples segmented in trimesters analyzed for 35 drugs [opioids, cocaine, amphetamines, Δ-tetrahydrocannabinol (THC),...

10.1097/ftd.0b013e318288453f article EN Therapeutic Drug Monitoring 2013-05-10

Drug determination in biological matrices from the mother and newborn is an objective measure of maternal fetal drug exposure. The aim this study was to compare hair, meconium, umbilical cord, placenta for detecting utero exposure cocaine, opiates, methadone, amphetamines.Maternal were collected 175 mother-newborn dyads. Maternal hair (segmented trimesters) meconium specimens analyzed amphetamines. If either or tested positive, cord analyzed. Analyses performed by liquid chromatography...

10.1097/ftd.0b013e31828a6148 article EN Therapeutic Drug Monitoring 2013-07-12

Abstract According to the 2014 National Survey on Drug Use and Health, 5.3% of pregnant women smoked marijuana in past month. This prevalence is expected increase as a growing number states countries are now considering legalization. Although umbilical cord becoming useful objective tool detect utero drug exposure, currently data about analytical methods its utility cannabis exposure scarce. The this work was develop method for determination Δ 9 ‐tetrahydrocannabinol (THC), 11‐hydroxyTHC...

10.1002/dta.2307 article EN Drug Testing and Analysis 2017-09-26
Coming Soon ...